William Plovanic
Stock Analyst at Canaccord Genuity
(2.49)
# 2,083
Out of 4,804 analysts
125
Total ratings
38.66%
Success rate
-0.14%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $7.27 | +147.59% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.50 | +100.00% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $33.10 | +57.10% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $75.41 | +37.91% | 5 | Mar 11, 2025 | |
| STIM Neuronetics | Maintains: Buy | $5 → $8 | $4.08 | +96.08% | 3 | Mar 5, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $63 | $17.61 | +257.75% | 3 | Feb 26, 2025 | |
| CBLL CeriBell | Maintains: Buy | $33 | $19.23 | +71.61% | 4 | Feb 26, 2025 | |
| DXCM DexCom | Maintains: Buy | $99 → $103 | $66.84 | +54.10% | 5 | Feb 14, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $68 → $71 | $69.90 | +1.57% | 25 | Feb 13, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $101 | $74.28 | +35.97% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $264.72 | +14.84% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $152 | $103.45 | +46.93% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $96.77 | +4.37% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.95 | +88.68% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $9.55 | +25.65% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $120 → $115 | $103.44 | +11.18% | 2 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $275.46 | +3.10% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.05 | +148.76% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $5.43 | +120.99% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $95.79 | -26.92% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $15.87 | +202.46% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.45 | +394.38% | 3 | Jul 25, 2023 |
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $7.27
Upside: +147.59%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.50
Upside: +100.00%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $33.10
Upside: +57.10%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $75.41
Upside: +37.91%
Neuronetics
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $4.08
Upside: +96.08%
Tandem Diabetes Care
Feb 26, 2025
Maintains: Buy
Price Target: $63
Current: $17.61
Upside: +257.75%
CeriBell
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $19.23
Upside: +71.61%
DexCom
Feb 14, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $66.84
Upside: +54.10%
Edwards Lifesciences
Feb 13, 2025
Maintains: Hold
Price Target: $68 → $71
Current: $69.90
Upside: +1.57%
Globus Medical
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $74.28
Upside: +35.97%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $264.72
Upside: +14.84%
Dec 9, 2024
Maintains: Buy
Price Target: $125 → $152
Current: $103.45
Upside: +46.93%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $96.77
Upside: +4.37%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.95
Upside: +88.68%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $9.55
Upside: +25.65%
Sep 10, 2024
Maintains: Hold
Price Target: $120 → $115
Current: $103.44
Upside: +11.18%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $275.46
Upside: +3.10%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.05
Upside: +148.76%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $5.43
Upside: +120.99%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $95.79
Upside: -26.92%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $15.87
Upside: +202.46%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.45
Upside: +394.38%